| Product Code: ETC12732975 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Neoantigen Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Neoantigen Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Neoantigen Market - Industry Life Cycle |
3.4 Thailand Neoantigen Market - Porter's Five Forces |
3.5 Thailand Neoantigen Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Thailand Neoantigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Thailand Neoantigen Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Thailand Neoantigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing investment in healthcare infrastructure and research and development activities in Thailand. |
4.2.2 Increasing prevalence of cancer cases, driving the demand for innovative treatment options like neoantigen therapies. |
4.2.3 Favorable government initiatives and policies supporting the development and adoption of advanced medical technologies. |
4.3 Market Restraints |
4.3.1 High cost associated with neoantigen therapies, limiting accessibility for a significant portion of the population. |
4.3.2 Limited awareness and understanding among healthcare professionals and patients about neoantigens and their therapeutic potential. |
4.3.3 Regulatory challenges and approval processes for new therapies in the Thai healthcare market. |
5 Thailand Neoantigen Market Trends |
6 Thailand Neoantigen Market, By Types |
6.1 Thailand Neoantigen Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Neoantigen Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Thailand Neoantigen Market Revenues & Volume, By Personalized Neoantigens, 2021 - 2031F |
6.1.4 Thailand Neoantigen Market Revenues & Volume, By Shared Neoantigens, 2021 - 2031F |
6.2 Thailand Neoantigen Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Thailand Neoantigen Market Revenues & Volume, By DNA Sequencing, 2021 - 2031F |
6.2.3 Thailand Neoantigen Market Revenues & Volume, By RNA Sequencing, 2021 - 2031F |
6.2.4 Thailand Neoantigen Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.3 Thailand Neoantigen Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Thailand Neoantigen Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.3.3 Thailand Neoantigen Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.3.4 Thailand Neoantigen Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.4 Thailand Neoantigen Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Thailand Neoantigen Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Thailand Neoantigen Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.4 Thailand Neoantigen Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
7 Thailand Neoantigen Market Import-Export Trade Statistics |
7.1 Thailand Neoantigen Market Export to Major Countries |
7.2 Thailand Neoantigen Market Imports from Major Countries |
8 Thailand Neoantigen Market Key Performance Indicators |
8.1 Number of clinical trials and research studies focused on neoantigen therapies in Thailand. |
8.2 Adoption rate of neoantigen therapies by leading healthcare institutions and oncology centers in the country. |
8.3 Investment trends in the biotechnology and pharmaceutical sectors specifically related to neoantigen research and development. |
9 Thailand Neoantigen Market - Opportunity Assessment |
9.1 Thailand Neoantigen Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Neoantigen Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Thailand Neoantigen Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Thailand Neoantigen Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Thailand Neoantigen Market - Competitive Landscape |
10.1 Thailand Neoantigen Market Revenue Share, By Companies, 2024 |
10.2 Thailand Neoantigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here